New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management

May 2005

New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management.

All Rx NSAIDs will have a new boxed warning about GI and cardiovascular risk. Patients will get a new Medication Guide when they fill their prescriptions.

Celebrex (celecoxib) will have a Medication Guide, plus a boxed warning, plus clinical trial data on cardiovascular risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

the legality of writing multiple C-II Rxs on the same day, for the same patient, for the same drug
Antithrombotics high-dose aspirin to prevent recurrent stroke from INTRACRANIAL arterial stenosis
Antithrombotics patients are caught by surprise when fad diets or special foods interfere with their warfarin therapy
Neurology & Pain New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management
Neurology & Pain certain generic versions of Duragesic don't seem to work as well
Bisphosphonates Boniva (ibandronate), the new once-MONTHLY bisphosphonate for osteoporosis
Bisphosphonates new warnings that bisphosphonates may cause jaw osteonecrosis
Infectious Diseases Baraclude (entecavir), a new oral antiviral for chronic hepatitis B
Infectious Diseases new IV antifungal, Mycamine (micafungin)
Thyroid Disorders Should patients with hypothyroidism be treated with both levothyroxine (Synthroid, etc) AND liothyronine (Cytomel)
Alzheimer's Disease Reminyl will be renamed Razadyne
Women's Health new form of Depo-Provera called Depo-subQ Provera 104
Women's Health New rumors suggest that Plan B is going OTC
Limbrel (flavocoxid) for osteoarthritis

New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents